PharmTech LCGC Sciex Webinar 11.10
|Articles|August 21, 2009

prominence TOX.I.S. (HPLC/PDA for identification of drugs in human urine)

Toxicological analysis of body fluids is an important task whenever acute intoxications, abuse of drugs or consumption of illicit drugs needs to be identified. Such analyses require a universal sample pretreatment and identification method and should be automated for speed and simplicity.

Toxicological analysis of body fluids is an important task whenever acute intoxications, abuse of drugs or consumption of illicit drugs needs to be identified. Such analyses require a universal sample pretreatment and identification method and should be automated for speed and simplicity.

The prominence TOX.I.S. system is based on prominence LC hardware modules using patented flow line design and column switching procedure to enable sample pretreatment of urine samples with a cleaning step, rinsing to remove proteins and other urine components, and transfer of the sample onto the analytical columns for separation.

Selection valves for the analytical columns make it possible to also use the system for analysis of blood/serum samples after a separate liquid/liquid extraction procedure or the determination of alcohol abuse marker (% CDT).

Detection and identification are achieved with photodiodearray detector and library search matches with UV spectra and relative retention time.

The application kits for the system are available from company RECIPE (www.recipe.de).

For further details visit our web page at www.shimadzu.eu


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.